Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,760 | 520 | 99.0% |
| Education | $261.70 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $5,940 | 126 | $0 (2024) |
| ViiV Healthcare Company | $5,847 | 108 | $0 (2024) |
| Novo Nordisk Inc | $3,602 | 57 | $0 (2024) |
| Janssen Products, LP | $3,412 | 30 | $0 (2023) |
| Janssen Biotech, Inc. | $2,450 | 123 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,417 | 33 | $0 (2023) |
| Amarin Pharma Inc. | $861.16 | 8 | $0 (2019) |
| Theratechnologies Inc. | $481.51 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $457.32 | 4 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $252.96 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,331 | 33 | ViiV Healthcare Company ($1,622) |
| 2023 | $4,379 | 71 | ViiV Healthcare Company ($1,345) |
| 2022 | $2,441 | 49 | Janssen Products, LP ($773.16) |
| 2021 | $2,835 | 88 | Gilead Sciences, Inc. ($706.81) |
| 2020 | $1,379 | 58 | ViiV Healthcare Company ($439.38) |
| 2019 | $4,589 | 84 | Gilead Sciences, Inc. ($1,551) |
| 2018 | $4,520 | 89 | Janssen Products, LP ($992.61) |
| 2017 | $3,548 | 53 | Gilead Sciences Inc ($918.75) |
All Payment Transactions
525 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 11/14/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: HIV | ||||||
| 11/07/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $132.35 | General |
| Category: HIV | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $149.89 | General |
| 10/03/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $130.32 | General |
| Category: HIV | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: HIV | ||||||
| 09/05/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: HIV | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 08/13/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: HIV | ||||||
| 08/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: HIV | ||||||
| 07/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: HIV | ||||||
| 06/28/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $83.54 | General |
| Category: HIV | ||||||
| 06/26/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: HIV | ||||||
| 06/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.73 | General |
| 06/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: HIV | ||||||
| 06/01/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: HIV | ||||||
| 05/29/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 05/28/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: HIV | ||||||
| 04/29/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: HIV | ||||||
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: HIV | ||||||
| 04/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 17 | 18 | $3,240 | $489.36 |
| 2021 | 1 | 22 | 50 | $9,000 | $2,748 |
| 2020 | 2 | 47 | 61 | $10,485 | $2,487 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 18 | $3,240 | $489.36 | 15.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 22 | 50 | $9,000 | $2,748 | 30.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 36 | 50 | $9,000 | $1,696 | 18.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 11 | $1,485 | $791.27 | 53.3% |
About Dr. Itha Harewood, M.D
Dr. Itha Harewood, M.D is a Internal Medicine healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124092952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Itha Harewood, M.D has received a total of $26,021 in payments from pharmaceutical and medical device companies, with $2,331 received in 2024. These payments were reported across 525 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($25,760).
As a Medicare-enrolled provider, Harewood has provided services to 86 Medicare beneficiaries, totaling 129 services with total Medicare billing of $5,724. Data is available for 3 years (2020–2022), covering 4 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bronx, NY
- Active Since 02/16/2006
- Last Updated 05/17/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124092952
Products in Payments
- DOVATO (Drug) $4,148
- SYMTUZA (Drug) $3,387
- PREZCOBIX (Drug) $1,529
- Ozempic (Drug) $1,410
- Epclusa (Drug) $1,278
- ISENTRESS (Drug) $897.79
- Symtuza (Drug) $872.37
- Vascepa (Drug) $861.16
- APRETUDE (Biological) $662.77
- TRIUMEQ (Drug) $563.89
- Descovy (Drug) $495.17
- Tresiba (Drug) $489.77
- Biktarvy (Drug) $483.38
- Wegovy (Drug) $448.76
- Victoza (Drug) $329.08
- ZEPATIER (Drug) $317.59
- EGRIFTA (Drug) $259.36
- RYBELSUS (Drug) $246.22
- Rybelsus (Drug) $245.37
- MOUNJARO (Drug) $243.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bronx
Timothy Kanter, M.d, M.D
Internal Medicine — Payments: $865,160
Dr. Jason Leider, M.d, M.D
Internal Medicine — Payments: $759,257
Bulent Atac, Md, MD
Internal Medicine — Payments: $654,500
Shervin Mortazavi, M.d, M.D
Internal Medicine — Payments: $402,598
Dr. Elizabeth Jenny-Avital
Internal Medicine — Payments: $176,355
Vivek Gumaste, M.d, M.D
Internal Medicine — Payments: $163,229